As of September 2024, Prestige BioPharma has a market cap of $601.28M. This makes Prestige BioPharma the world's 10373th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $376.64M | -10.86% |
2023 | $422.55M | 29.33% |
2022 | $326.72M | -64.84% |
2021 | $929.34M | - |